Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care.
about
The use of antiarrhythmics prior to cardioversion or catheter ablation for atrial fibrillationThe use of antiarrhythmics prior to cardioversion or catheter ablation for atrial fibrillationIs self-monitoring an effective option for people receiving long-term vitamin K antagonist therapy? A systematic review and economic evaluationThe safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort studyA national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in ScotlandScreening for atrial fibrillation in 13 122 Hong Kong citizens with smartphone electrocardiogram.Trends in the prevalence and management of pre-stroke atrial fibrillation, the South London Stroke Register, 1995-2014.Cardiovascular medication utilization and adherence among adults living in rural and urban areas: a systematic review and meta-analysis.Epidemiology and Management of Atrial Fibrillation and Stroke: Review of Data from Four European Countries.A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study.RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers.Patterns of warfarin use in subgroups of patients with atrial fibrillation: a cross-sectional analysis of 430 general practices in the United Kingdom.Frequency and risk factors for under- and over-treatment in stroke prevention for patients with non-valvular atrial fibrillation in general practice.Socioeconomic status influences the likelihood but not the outcome of liver resection for colorectal liver metastasis.Holmium Laser Enucleation of the Prostate: Comparison of Immediate Postoperative Outcomes in Patients with and without Antithrombotic Therapy.Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation.Spurious trends in coronary heart disease incidence: unintended consequences of the new GP contract?Status of the epidemiology of atrial fibrillation.Prevalence and Risk Factors of Atrial Fibrillation in Chinese Elderly: Results from the Chinese Longitudinal Healthy Longevity Survey.Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000-2009An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocolThe Association Between Bleeding and the Incidence of Warfarin Discontinuation in Patients with Atrial FibrillationTrends and inequities in beta-blocker prescribing for heart failure.The use of anticoagulants in the management of atrial fibrillation among general practices in EnglandEuropean Society of Cardiology Guideline-Adherent Antithrombotic Treatment and Risk of Mortality in Asian Patients with Atrial FibrillationEarly real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care.An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes.Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.Hiatal Hernia Is Associated With an Increased Prevalence of Atrial Fibrillation in Young Patients.What is the role of the cardiologist in future management of stroke prevention in atrial fibrillation?The efficacy of intraoperative atrial radiofrequency ablation for atrial fibrillation during concomitant cardiac surgery-the Surgical Atrial Fibrillation Suppression (SAFS) Study.The effect of oral anticoagulation on the prevalence and management of haematuria in a contemporary Australian patient cohort.The prevalence, impact and economic implications of atrial fibrillation in stroke: what progress has been made?Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey.A review of apixaban for stroke prevention in atrial fibrillation: insights from ARISTOTLE.Novel anticoagulants for stroke prevention in patients with atrial fibrillation.Identifying the clinical characteristics of older people living in care homes using a novel approach in a primary care database.Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?New frontiers in anticoagulation: non vitamin-K oral anticoagulants in stroke prevention.Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections.
P2860
Q24188262-2F7F61FF-F1C6-43D9-B586-E74B4C8CC1ADQ24201163-250C6E30-5BEB-4BC8-B0EC-B21340F203E2Q28081070-168FA102-2C76-4269-B670-E693D6A09885Q28200425-57566A23-BFC2-4664-8FA5-42BD2D2ED180Q28218708-C649D654-E39B-4261-9853-D78316BC2AFFQ33451086-F912A605-D063-44A3-8DD6-944C2C47B5B9Q33565534-A45B04B5-6D9D-45B5-8F6B-60E2F3C05515Q33783232-33008CFB-A4BD-4CEB-BE45-1D8E9DFA9759Q33786841-EE5A96B3-97C2-4DEF-9A0E-D9894808D53AQ34317469-3B328637-26C5-4C8F-A06F-8CEA83D4A8AFQ34432030-AFBCDA65-28EB-4EDF-9572-504867168A4EQ34712397-117CCD78-BB03-4CA4-802A-36ADB4387F50Q34826211-56ED77D0-113F-4AF6-A671-120B79C4F2FFQ34986186-DB9FC080-3DC1-429B-8551-977E8F8C4E70Q35185261-8E66BD97-D23A-4F96-BD2F-96B726E86DCFQ35841464-25B8BC62-F423-49F7-86BC-FE07567CF409Q36144574-9DB6622F-68ED-443B-9EE7-6EA41323D112Q36464561-30FA8CDB-E6ED-4073-B533-83F32BFB8BD0Q36498499-F11DE6A9-AF39-4572-AFEF-A785B350E33BQ36550795-02373CCB-B9AC-4B51-A4D2-2DB7DDC73453Q36805599-351FAD54-C53C-4EB2-AFBC-6D9C010794D2Q36847664-A0FC55A7-6728-4E21-9336-7567589F199DQ36995236-CA6C0C26-B523-49D4-A4BB-F6EA37018C3BQ37030961-413BA7C8-6D21-4B54-BAFB-35336BDA4420Q37157549-8FFE3A1A-E032-40E2-ADF5-3D88B7B4A756Q37312543-D1F2D44F-C11A-444F-904C-F4BA9599CCEDQ37328680-31552500-4D3E-45F8-BB29-3866DE01F608Q37380393-CAC03C9A-3637-482E-A0C3-10D588FFAA2AQ37496329-7AA1FD0E-BE42-4105-9590-54E340EBC157Q37820332-7E61A51A-505A-4257-9A60-81574D792CCAQ37891846-57F5DA19-DB5A-4478-9DDA-B1DB4045CC8BQ38063559-10D3A5A3-F748-42EB-BDBE-2CE6038A8C47Q38077894-7005C95A-D228-4E91-A8FA-EF058C965645Q38106663-4C619FB5-79F3-4CDB-9C40-8AA2CFB3949FQ38132927-69DBBDBE-CC12-4289-8CF6-068521343730Q38212962-2F1D0972-1C02-48A5-BD7B-C8099615A947Q38371802-30531DC3-5F22-47DB-A405-0DD3922BD538Q38728028-E7816420-9C6F-40ED-9CF0-6C85B6E0DAD9Q39027027-58FD0ED5-43BD-4F8F-B6F7-CAFD9E1AEA3CQ39752854-D6A9B363-C260-421F-8C14-B54A0D8EDB79
P2860
Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Trends in the prevalence of di ...... treatment in UK primary care.
@ast
Trends in the prevalence of di ...... treatment in UK primary care.
@en
type
label
Trends in the prevalence of di ...... treatment in UK primary care.
@ast
Trends in the prevalence of di ...... treatment in UK primary care.
@en
prefLabel
Trends in the prevalence of di ...... treatment in UK primary care.
@ast
Trends in the prevalence of di ...... treatment in UK primary care.
@en
P2093
P2860
P356
P1433
P1476
Trends in the prevalence of di ...... treatment in UK primary care.
@en
P2093
P2860
P304
P356
10.1136/HRT.2005.069492
P407
P577
2005-12-30T00:00:00Z